BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36990350)

  • 21. Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma.
    Liu L; Li L; Ding Y; Kong F; Mo W; Ye H; Shen D
    Diagn Pathol; 2024 Jan; 19(1):19. PubMed ID: 38254207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
    He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
    Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation.
    Milione M; Gasparini P; Sozzi G; Mazzaferro V; Ferrari A; Casali PG; Perrone F; Tamborini E; Pellegrinelli A; Gherardi G; Arrigoni G; Collini P; Testi A; De Paoli E; Aiello A; Pilotti S; Pelosi G
    Histopathology; 2014 Jun; 64(7):1014-26. PubMed ID: 24898918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid endobronchial tumor with EWSR1-FLI1 fusion gene - A diagnostically challenging case of the Ewing sarcoma.
    Kirishima M; Kato I; Hisaoka M; Nakatani Y; Takeda AH; Mizuno K; Tanimoto A
    Pathol Int; 2021 Jul; 71(7):488-490. PubMed ID: 34111315
    [No Abstract]   [Full Text] [Related]  

  • 25. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
    Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.
    Warren M; Weindel M; Ringrose J; Venable C; Reyes A; Terashima K; Rao P; Chintagumpala M; Hicks MJ; Lopez-Terrada D; Lu XY
    Hum Pathol; 2013 Oct; 44(10):2010-9. PubMed ID: 23706910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis.
    García-Domínguez DJ; Hontecillas-Prieto L; León EA; Sánchez-Molina S; Rodríguez-Núñez P; Morón FJ; Hajji N; Mackintosh C; de Álava E
    PLoS One; 2020; 15(6):e0234243. PubMed ID: 32502203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
    Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
    Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary superficial Ewing sarcoma: A unique entity? A case report including novel findings of ELF3 and TNFRSF14 copy number loss.
    Murphy LD; Orman GM; Bridge JA; Bajaj G; Gardner JM; Douglass DP
    J Cutan Pathol; 2020 Oct; 47(10):970-975. PubMed ID: 32483824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
    Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
    J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma.
    Krumbholz M; Hellberg J; Steif B; Bäuerle T; Gillmann C; Fritscher T; Agaimy A; Frey B; Juengert J; Wardelmann E; Hartmann W; Juergens H; Dirksen U; Metzler M
    Clin Cancer Res; 2016 Sep; 22(17):4356-65. PubMed ID: 27283964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Intracranial Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Mimicking Meningioma: A Case Report and Literature Review.
    Jiang Y; Zhao L; Wang Y; Liu X; Wu X; Li Y
    Front Oncol; 2020; 10():528073. PubMed ID: 33123461
    [No Abstract]   [Full Text] [Related]  

  • 34. HNRNPH1-dependent splicing of a fusion oncogene reveals a targetable RNA G-quadruplex interaction.
    Neckles C; Boer RE; Aboreden N; Cross AM; Walker RL; Kim BH; Kim S; Schneekloth JS; Caplen NJ
    RNA; 2019 Dec; 25(12):1731-1750. PubMed ID: 31511320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD43-positive, EWSR1::FLI1 -rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic Leukemia.
    Ohlsen TJD; Rudzinski ER; Bohling SD; Liu YJ; Maloney EJ; Lindberg AW; Albert CM; Lamble AJ; Taylor MR
    J Pediatr Hematol Oncol; 2023 Jul; 45(5):e635-e638. PubMed ID: 37027334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral-type primitive neuroectodermal tumor of the ovary with EWSR1-FLI1 fusion transcript: a case report and brief review of literature.
    Grigoriu C; Terzea DC; Lisievici AC; Georgescu TA; Constantin AE; Bacalbaşa N; Ducu I; Bohîlţea RE
    Rom J Morphol Embryol; 2021; 62(2):581-586. PubMed ID: 35024748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor.
    Sumegi J; Nishio J; Nelson M; Frayer RW; Perry D; Bridge JA
    Mod Pathol; 2011 Mar; 24(3):333-42. PubMed ID: 21113140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
    Grünewald TG; Bernard V; Gilardi-Hebenstreit P; Raynal V; Surdez D; Aynaud MM; Mirabeau O; Cidre-Aranaz F; Tirode F; Zaidi S; Perot G; Jonker AH; Lucchesi C; Le Deley MC; Oberlin O; Marec-Bérard P; Véron AS; Reynaud S; Lapouble E; Boeva V; Rio Frio T; Alonso J; Bhatia S; Pierron G; Cancel-Tassin G; Cussenot O; Cox DG; Morton LM; Machiela MJ; Chanock SJ; Charnay P; Delattre O
    Nat Genet; 2015 Sep; 47(9):1073-8. PubMed ID: 26214589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Intracranial Ewing Sarcoma With
    Hyun C; Lee Y; Kang H; Park HJ; Suh KJ; Choi BS; Choe G; Kim CY
    Brain Tumor Res Treat; 2023 Oct; 11(4):281-288. PubMed ID: 37953453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival.
    Gallegos ZR; Taus P; Gibbs ZA; McGlynn K; Gomez NC; Davis I; Whitehurst AW
    Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31036566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.